Delivery Order SPE2DB22D2103-SPE2DB24FR9YY
Award Date
9/17/24
Potential Completion Date
9/18/24
Potential Value
$37K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,232.60, is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,185,984 units of the medication Vraylar 1.5 mg capsule. The contract has a ceiling value of $1,409.56 and an ultimate completion date of October 24, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,452.90, is for the delivery of Vraylar 3 mg capsules over the period ending on May 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The $5,593.96 firm fixed-price contract has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,142,669 units of Vraylar 3 mg capsules. The total ceiling value of the contract is $5,905.92 and the ultimate completion date is May 6, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,705.67 firm fixed-price contract is for the supply of 4,565,683,431 units of the prescription drug Vraylar 3 mg capsules. The contract has a period of performance through September 5, 2024 and does not utilize any set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Vraylar 1.5 mg capsules. The contract has a firm fixed price of $3,786.62 and a completion date of June 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,941.41, is for the supply of Vraylar 3 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,248.08 firm fixed-price contract is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 4.5 mg capsules. The contract has a ceiling value of $7,424.32 and a completion date of May 29, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...